Previous 10 | Next 10 |
FRANKLIN, Tenn., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Today, Clover Health (“Clover” or “the Company”) issued an analysis titled Clover Assistant Use and Diagnosis, Treatment, and Progression of Diabetes , which examines the association between use of ...
FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medica...
2023-09-06 17:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-08-24 07:20:35 ET Clover Health (NASDAQ: CLOV) stock price has pulled back in the past few days as the recent uptrend eased. The shares were trading at $1.30 on Thursday, lower than this month’s high of $1.63. They remain about 88% from the lowest level this year. Facing...
2023-08-18 12:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-08-09 10:08:11 ET Gainers: Tango Therapeutics ( TNGX ) +137% . Decibel Therapeutics ( DBTX ) +72% . Mirati Therapeutics ( MRTX ) +26% . Azenta ( AZTA ) +25% . Clover Health Investments ( CLOV ) +18 % . Losers: ...
2023-08-08 21:34:11 ET Start Time: 17:00 End Time: 17:36 Clover Health Investments, Corp. (CLOV) Q2 2023 Earnings Conference Call August 08, 2023, 17:00 PM ET Company Participants Andrew Toy - CEO Scott Leffler - CFO Ryan Schmidt - IR Conference Cal...
2023-08-08 16:11:25 ET Clover Health press release ( NASDAQ: CLOV ): Q2 net loss of $28.8M. Revenue of $513.63M (-39.3% Y/Y) beats by $22.81M . 2023 Outlook: Insurance revenue is expected to be in the range of $1.20 billion to $1.23 billion in 2023, a growth ra...
Insurance revenue grew 17% compared to Q2'22, and second quarter Insurance MCR improved to 77.2% , bringing first half MCR to 81.9% Company reports Q2 Net Loss of $28.8 million , and Adjusted EBITDA profit of $10.0 million Improved 2023 guidance i...
2023-08-04 06:15:20 ET Clover Health Investments ( NASDAQ: CLOV ) receives Nasdaq notice that it has regained compliance with the minimum bid price requirement. The company had received a notice from Nasdaq on April 20, 2023 notifying that it had failed to meet the $1.00 p...
News, Short Squeeze, Breakout and More Instantly...
Clover Health Investments Corp. Company Name:
CLOV Stock Symbol:
NYSE Market:
Clover Health Investments Corp. Website:
FRANKLIN, Tenn., July 22, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover Health”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will report second quarte...
FRANKLIN, Tenn., June 14, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement technology company committed to bringing access to great healthcare to everyone on Medi...
FRANKLIN, Tenn., May 29, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”) , a physician enablement technology company committed to bringing access to great healthcare to everyone on ...